Advanced Gastroesophageal Junction Adenocarcinoma

Advanced Gastroesophageal Junction Adenocarcinoma is the indication for 2 drugs in DrugBank. It is covered by 7 curated, structured indications.

Also known as: advanced gastro-esophageal junction adenocarcinoma
Classified under: Gastrointestinal Tract Disorders
Neoplasms
Neoplasms, Glandular and Epithelial
Indicated drugs: Hyaluronidase (human recombinant)
Nivolumab

What you can answer from here — as of October 23, 2026

2Indicated drugsWith each drug's targets and mechanism

Listed above

7Structured indicationsPopulation, line of therapy, route and combination as fields, not prose

26Clinical trialsPhase, status and sponsor resolved per trial

Which approved drugs for Advanced Gastroesophageal Junction Adenocarcinoma share a target, and which companies have late-stage candidates against it?

Create a free account or log in to explore the full data card.